Skip to main content
Erschienen in: The Cerebellum 3/2010

01.09.2010

Progression Rate of Neurological Deficits in a 10-Year Cohort of SCA3 Patients

verfasst von: Laura Bannach Jardim, Lisiane Hauser, Christian Kieling, Jonas Alex Morales Saute, Renan Xavier, Carlos Roberto Mello Rieder, Thais Lampert Monte, Suzi Camey, Vanessa Bielefeld Leotti Torman

Erschienen in: The Cerebellum | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Spinocerebellar ataxia 3 is an untreatable CAG repeat expansion disorder whose natural history is not completely understood. Our aims were to describe the progression of neurological manifestations in a long-term cohort of spinocerebellar ataxia 3, and to verify if CAG expanded repeat, gender, and age at onset were associated with the rate of progression. Patients entered the study between 1998 and 2005 and were seen until 2007. On each visit, the validated NESSCA scale, an inventory of 18 neurological manifestations, was applied. Scores observed in each year of disease duration produced a Growth Curve, which was analyzed through the random coefficients model. Scores obtained in some individual items were described through multi-state Markov models. One hundred fifty-six patients (78 families) were recruited; 28 were lost, and 23 died. Mean (sd) ages at onset and at baseline were 32.8 (10.6) and 40.7 (12.8) years; median (range) expanded CAGn was 74 (67–85). Three hundred fifteen NESSCA evaluations were performed, comprising disease durations from zero to 34 years. The 105 patients who completed the study were seen over 5 (sd = 2.4) years at intervals of 2.5 (sd = 1.5) years. The trajectory of NESSCA obtained for the overall group increased by 1.26 points per year. This slope increased by 0.15 points per each additional CAG in the expanded repeat (p < 0.0002) and decreased by 0.03 points per each additional year of age at onset (p = 0.005). NESSCA worsened steadily, producing linear trajectories, which were faster among patients with longer expanded repeats (>74) and with lower ages at onset (<34 years).
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Takiyama Y, Nishizawa M, Tanaka H, Kawashima S, Sakamoto H, Karube Y, et al. The gene for Machado–Joseph disease maps to human chromosome 14q. Nat Genet. 1993;4:300–4.CrossRefPubMed Takiyama Y, Nishizawa M, Tanaka H, Kawashima S, Sakamoto H, Karube Y, et al. The gene for Machado–Joseph disease maps to human chromosome 14q. Nat Genet. 1993;4:300–4.CrossRefPubMed
2.
Zurück zum Zitat Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, et al. CAG expansions in a novel gene for Machado–Joseph disease at chromosome 14q32.1. Nat Genet. 1994;8:221–8.CrossRefPubMed Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, et al. CAG expansions in a novel gene for Machado–Joseph disease at chromosome 14q32.1. Nat Genet. 1994;8:221–8.CrossRefPubMed
3.
Zurück zum Zitat Prestes PR, Pereira MLS, Silveira I, Sequeiros J, Jardim LB. Machado–Joseph Disease enhances genetic fitness: a comparison between affected and unaffected women and between MJD and the general population. Ann Hum Genet. 2007;72:57–64.PubMed Prestes PR, Pereira MLS, Silveira I, Sequeiros J, Jardim LB. Machado–Joseph Disease enhances genetic fitness: a comparison between affected and unaffected women and between MJD and the general population. Ann Hum Genet. 2007;72:57–64.PubMed
4.
Zurück zum Zitat Sequeiros J, Martins S, Silveira I (2010). Epidemiology and population genetics of degenerative ataxias. In: Subramony S, Dürr A, editors. Ataxic Disorders. Handbook of Neurological Disorders. Amsterdam, Elsevier; in press. Sequeiros J, Martins S, Silveira I (2010). Epidemiology and population genetics of degenerative ataxias. In: Subramony S, Dürr A, editors. Ataxic Disorders. Handbook of Neurological Disorders. Amsterdam, Elsevier; in press.
5.
Zurück zum Zitat Kieling C, Prestes PR, Saraiva-Pereira ML, Jardim LB. Survival estimates for patients with Machado–Joseph disease (SCA3). Clin Genet. 2007;72(6):543–5.CrossRefPubMed Kieling C, Prestes PR, Saraiva-Pereira ML, Jardim LB. Survival estimates for patients with Machado–Joseph disease (SCA3). Clin Genet. 2007;72(6):543–5.CrossRefPubMed
6.
Zurück zum Zitat Sequeiros J, Coutinho P. Epidemiology and clinical aspects of Machado-Joseph Disease. In: Harding A, Deufel T, Chamberlain S, editors. Hereditary Ataxias. New York: Raven; 1993. p. 139–53. Sequeiros J, Coutinho P. Epidemiology and clinical aspects of Machado-Joseph Disease. In: Harding A, Deufel T, Chamberlain S, editors. Hereditary Ataxias. New York: Raven; 1993. p. 139–53.
7.
Zurück zum Zitat Tuite PJ, Rogaeva EA, St George Hyslop PH, Lang AE. Dopa-responsive parkinsonism phenotype of Machado–Joseph disease: confirmation of 14q CAG expansion. Ann Neurol. 1995;38(4):684–7.CrossRefPubMed Tuite PJ, Rogaeva EA, St George Hyslop PH, Lang AE. Dopa-responsive parkinsonism phenotype of Machado–Joseph disease: confirmation of 14q CAG expansion. Ann Neurol. 1995;38(4):684–7.CrossRefPubMed
8.
Zurück zum Zitat Dürr A, Stevanin G, Cancel G, Duyckaerts C, Abbas N, Didierjean O, et al. Spinocerebellar ataxia 3 and Machado–Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol. 1996;39(4):490–9.CrossRefPubMed Dürr A, Stevanin G, Cancel G, Duyckaerts C, Abbas N, Didierjean O, et al. Spinocerebellar ataxia 3 and Machado–Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol. 1996;39(4):490–9.CrossRefPubMed
9.
Zurück zum Zitat Van Schaik IN, Jöbsis GJ, Vermeulen M, Keizers H, Bolhuis PA, de Visser M. Machado–Joseph disease presenting as severe asymmetric proximal neuropathy. J Neurol Neurosurg Psychiatry. 1997;63(4):534–6.CrossRefPubMed Van Schaik IN, Jöbsis GJ, Vermeulen M, Keizers H, Bolhuis PA, de Visser M. Machado–Joseph disease presenting as severe asymmetric proximal neuropathy. J Neurol Neurosurg Psychiatry. 1997;63(4):534–6.CrossRefPubMed
10.
Zurück zum Zitat Schöls L, Amoiridis G, Büttner T, Przuntek H, Epplen JT, Riess O. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes? Ann Neurol. 1997;42(6):924–32.CrossRefPubMed Schöls L, Amoiridis G, Büttner T, Przuntek H, Epplen JT, Riess O. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes? Ann Neurol. 1997;42(6):924–32.CrossRefPubMed
11.
Zurück zum Zitat Abele M, Bürk K, Andres F, Topka H, Laccone F, Bösch S, et al. Autosomal dominant cerebellar ataxia type I. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3. Brain. 1997;120(Pt 12):2141–8.CrossRefPubMed Abele M, Bürk K, Andres F, Topka H, Laccone F, Bösch S, et al. Autosomal dominant cerebellar ataxia type I. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3. Brain. 1997;120(Pt 12):2141–8.CrossRefPubMed
12.
Zurück zum Zitat Schöls L, Haan J, Riess O, Amoiridis G, Przuntek H. Sleep disturbance in spinocerebellar ataxias: is the SCA3 mutation a cause of restless legs syndrome? Neurology. 1998;51(6):1603–7.PubMed Schöls L, Haan J, Riess O, Amoiridis G, Przuntek H. Sleep disturbance in spinocerebellar ataxias: is the SCA3 mutation a cause of restless legs syndrome? Neurology. 1998;51(6):1603–7.PubMed
13.
Zurück zum Zitat Jardim LB, Pereira ML, Silveira I, Ferro A, Sequeiros J, Giugliani R. Neurologic findings in Machado–Joseph disease. Arch Neurol. 2001;58:899–904.CrossRefPubMed Jardim LB, Pereira ML, Silveira I, Ferro A, Sequeiros J, Giugliani R. Neurologic findings in Machado–Joseph disease. Arch Neurol. 2001;58:899–904.CrossRefPubMed
14.
Zurück zum Zitat Bürk K, Globas C, Bösch S, Klockgether T, Zühlke C, Daum I, et al. Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol. 2003;250(2):207–11.CrossRefPubMed Bürk K, Globas C, Bösch S, Klockgether T, Zühlke C, Daum I, et al. Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol. 2003;250(2):207–11.CrossRefPubMed
15.
Zurück zum Zitat Zilber N, Manor O, Inzelberg R, Kahana E, Korczyn AD. A statistical method for quantitative evaluation of the progression of chronic diseases: the mean score graph (MSG). Stat Med. 1998;17(20):2395–403.CrossRefPubMed Zilber N, Manor O, Inzelberg R, Kahana E, Korczyn AD. A statistical method for quantitative evaluation of the progression of chronic diseases: the mean score graph (MSG). Stat Med. 1998;17(20):2395–403.CrossRefPubMed
16.
Zurück zum Zitat Klockgether T, Lüdtke R, Kramer B, Abele M, Bürk K, Schöls L, et al. The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain. 1998;121:589–600.CrossRefPubMed Klockgether T, Lüdtke R, Kramer B, Abele M, Bürk K, Schöls L, et al. The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain. 1998;121:589–600.CrossRefPubMed
17.
Zurück zum Zitat Camey S, Jardim LB, Kieling C, Saute JAM, Vigo A. A prospective study of SCA3 gait ataxia described through a Markovian method. Neuroepidemiology. 2010;34:163–70.CrossRefPubMed Camey S, Jardim LB, Kieling C, Saute JAM, Vigo A. A prospective study of SCA3 gait ataxia described through a Markovian method. Neuroepidemiology. 2010;34:163–70.CrossRefPubMed
18.
Zurück zum Zitat Martins S, Coutinho P, Silveira I, Giunti P, Jardim LB, Calafell F, et al. Cis-acting factors promoting the CAG intergenerational instability in Machado–Joseph disease. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(4):439–46.CrossRefPubMed Martins S, Coutinho P, Silveira I, Giunti P, Jardim LB, Calafell F, et al. Cis-acting factors promoting the CAG intergenerational instability in Machado–Joseph disease. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(4):439–46.CrossRefPubMed
19.
Zurück zum Zitat Kieling C, Rieder CR, Silva AC, Saute JA, Cecchin CR, Monte TL, et al. A neurological examination score for the assessment of spinocerebellar ataxia 3(SCA3). Eur J Neurol. 2008;15(4):371–6.CrossRefPubMed Kieling C, Rieder CR, Silva AC, Saute JA, Cecchin CR, Monte TL, et al. A neurological examination score for the assessment of spinocerebellar ataxia 3(SCA3). Eur J Neurol. 2008;15(4):371–6.CrossRefPubMed
20.
Zurück zum Zitat Singer JD. Using SAS proc mixed to fit multilevel models, hierarchical models, and individual growth models. J Educ Behav Stat. 1998;24:323–55. Singer JD. Using SAS proc mixed to fit multilevel models, hierarchical models, and individual growth models. J Educ Behav Stat. 1998;24:323–55.
22.
Zurück zum Zitat R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, 2009. http://www.R-project.org. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, 2009. http://​www.​R-project.​org.
23.
Zurück zum Zitat Yanjanin NM, Vélez JI, Gropman A, King K, Bianconi SE, Conley SK, et al. Linear clinical progression, independent of age of onset, in Niemann–Pick disease, type C. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(1):132–40.PubMed Yanjanin NM, Vélez JI, Gropman A, King K, Bianconi SE, Conley SK, et al. Linear clinical progression, independent of age of onset, in Niemann–Pick disease, type C. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(1):132–40.PubMed
24.
Zurück zum Zitat Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci. 1997;145(2):205–11.CrossRefPubMed Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci. 1997;145(2):205–11.CrossRefPubMed
25.
Zurück zum Zitat França Jr MC, D'Abreu A, Nucci A, Cendes F, Lopes-Cendes I. Progression of ataxia in patients with Machado–Joseph disease. Mov Disord. 2009;15;24(9):1387–90.CrossRef França Jr MC, D'Abreu A, Nucci A, Cendes F, Lopes-Cendes I. Progression of ataxia in patients with Machado–Joseph disease. Mov Disord. 2009;15;24(9):1387–90.CrossRef
Metadaten
Titel
Progression Rate of Neurological Deficits in a 10-Year Cohort of SCA3 Patients
verfasst von
Laura Bannach Jardim
Lisiane Hauser
Christian Kieling
Jonas Alex Morales Saute
Renan Xavier
Carlos Roberto Mello Rieder
Thais Lampert Monte
Suzi Camey
Vanessa Bielefeld Leotti Torman
Publikationsdatum
01.09.2010
Verlag
Springer-Verlag
Erschienen in
The Cerebellum / Ausgabe 3/2010
Print ISSN: 1473-4222
Elektronische ISSN: 1473-4230
DOI
https://doi.org/10.1007/s12311-010-0179-4

Weitere Artikel der Ausgabe 3/2010

The Cerebellum 3/2010 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.